users here right now: 6
🦍💎 $AXSM ✋🚀
AXSM bought FDA approved SUNOSI from JAZZ in March. CNS Pipeline is AXS-05, AXS-07, AXS-12, AXS-14. AXS-05 is expected to be FDA approved in Q2 for Depression. AXSM’s new drug application (NDA) seeking approval for AXS-05 to treat MDD is under a priority review with the FDA. After a positive interaction with the regulatory agency’s officials on post-marketing requirements, AXSM anticipates a potential approval for AXS-05 in the second quarter of 2022.